Lexicon Pharmaceuticals to Participate at the Jefferies 2025 London Healthcare Conference

Group 1 - Lexicon Pharmaceuticals will participate in a fireside chat at the Jefferies 2025 London Healthcare Conference on November 18, 2025 [1] - The event will be accessible live and via replays on the company's website [1] Group 2 - Lexicon Pharmaceuticals is a biopharmaceutical company focused on pioneering medicines that transform patients' lives [2] - The company has developed a unique genomics target discovery platform called Genome5000™, studying nearly 5,000 genes and identifying over 100 protein targets with therapeutic potential [2] - Lexicon has multiple medicines on the market and a pipeline of drug candidates in various stages of development for conditions such as heart failure, neuropathic pain, obesity, cardiology, and diabetes [2]